Targeting the inflammasome in cardiovascular disease

MB Olsen, I Gregersen, Ø Sandanger, K Yang… - Basic to Translational …, 2022 - jacc.org
The pathogenesis of cardiovascular disease (CVD) is complex and multifactorial, and
inflammation plays a central role. Inflammasomes are multimeric protein complexes that are …

Leptin-aldosterone-neprilysin axis: identification of its distinctive role in the pathogenesis of the three phenotypes of heart failure in people with obesity

M Packer - Circulation, 2018 - Am Heart Assoc
Obesity (especially visceral adiposity) can be associated with 3 different phenotypes of heart
failure: heart failure with a reduced ejection fraction, heart failure with a preserved ejection …

Interleukin-1 blockade in recently decompensated systolic heart failure: results from REDHART (Recently Decompensated Heart Failure Anakinra Response Trial)

BW Van Tassell, J Canada, S Carbone… - Circulation: Heart …, 2017 - Am Heart Assoc
Background An enhanced inflammatory response predicts worse outcomes in heart failure
(HF). We hypothesized that administration of IL-1 (interleukin-1) receptor antagonist …

Interleukin-1 blockade in cardiovascular diseases: a clinical update

LF Buckley, A Abbate - European heart journal, 2018 - academic.oup.com
Abstract Interleukin-1 (IL-1) is the prototypical pro-inflammatory cytokine. IL-1 was implicated
as a cardiodepressant factor in septic shock, and subsequent pre-clinical and clinical …

Il-1 blockade in patients with heart failure with preserved ejection fraction: Results from dhart2

BW Van Tassell, CR Trankle, JM Canada… - Circulation: Heart …, 2018 - Am Heart Assoc
Background Enhanced inflammation may lead to exercise intolerance in heart failure with
preserved ejection fraction. The aim of the current study was to determine whether IL …

Fir (e) ing the rhythm: inflammatory cytokines and cardiac arrhythmias

PE Lazzerini, A Abbate, M Boutjdir… - Basic to Translational …, 2023 - jacc.org
Inflammatory activation is increasingly recognized as a nonconventional risk factor for
arrhythmias, and experimental studies provided robust evidence that this association is …

A review of interleukin-1 in heart disease: where do we stand today?

Y Szekely, Y Arbel - Cardiology and therapy, 2018 - Springer
Cardiovascular diseases are the leading cause of death worldwide. Research in the last two
decades has emphasized the inflammatory process as a key component in the …

Phase 1b, randomized, double-blinded, dose escalation, single-center, repeat dose safety and pharmacodynamics study of the oral nlrp3 inhibitor dapansutrile in …

GF Wohlford, BW Van Tassell… - Journal of …, 2021 - journals.lww.com
The NLRP3 inflammasome has been implicated in the development and progression of
heart failure. The aim of this study was to determine the safety of an oral inhibitor of the …

Inflammation as a precursor of atherothrombosis, diabetes and early vascular aging

E Barbu, MR Popescu, AC Popescu… - International Journal of …, 2022 - mdpi.com
Vascular disease was for a long time considered a disease of the old age, but it is becoming
increasingly clear that a cumulus of factors can cause early vascular aging (EVA) …

The role of the inflammasome in heart failure

J Wu, E Dong, Y Zhang, H Xiao - Frontiers in physiology, 2021 - frontiersin.org
Inflammation promotes the development of heart failure (HF). The inflammasome is a
multimeric protein complex that plays an essential role in the innate immune response by …